Gelatin Empty Capsule

Gelatin Empty Capsule Market Outlook

The global gelatin empty capsule market is anticipated to reach USD 4.45 billion by 2035, growing at a remarkable compound annual growth rate (CAGR) of 8.5% from 2025 to 2035. The growth of this market can be attributed to several factors, including the rising demand for capsules over traditional tablets due to the ease of ingestion, the growing pharmaceutical industry, and an increasing focus on innovative drug delivery systems. Additionally, the rise in health awareness and the growing trend of self-medication have significantly fueled the demand for health supplements in capsule form. Increasing R&D activities in pharmaceuticals are also expected to bolster market growth as manufacturers continue to develop novel formulations requiring advanced drug delivery mechanisms. Furthermore, the rapid expansion of the nutraceutical segment is expected to make a notable contribution to the market dynamics.

Growth Factor of the Market

The gelatin empty capsule market is experiencing substantial growth driven by several key factors. Firstly, the increasing consumer preference for capsules due to their ease of consumption, especially among the aging population, is a crucial factor. Capsules are often viewed as more palatable than tablets, thus encouraging their use for both pharmaceutical and dietary supplement applications. Secondly, advancements in capsule technology, such as the development of vegetarian alternatives to traditional gelatin capsules, are expanding the market appeal to a broader consumer base who may have dietary restrictions. Moreover, the rise in chronic diseases has led to an increased prescription of medications, further boosting the demand for gelatin capsules in the pharmaceutical sector. The growing popularity of customized health supplements is also contributing to the market since many health-conscious consumers prefer encapsulated products that align with their specific nutritional needs. Lastly, the rapid growth of the online pharmacy sector is enhancing accessibility to various capsule products, thereby promoting market growth.

Key Highlights of the Market

• The global gelatin empty capsule market is projected to reach USD 4.45 billion by 2035.
• Pharmaceutical applications account for the largest share of the market.
• Hard gelatin capsules are widely preferred due to their cost-effectiveness and efficiency.
• Asia Pacific is expected to witness the highest growth rate in the forecast period.
• The growth of the nutraceutical market is driving innovations in gelatin capsule formulations.

By Product Type

Hard Gelatin Capsules:

Hard gelatin capsules are the most extensively used type in the industry, accounting for a significant share of the gelatin empty capsule market. These capsules are composed of two parts: a body and a cap, allowing for easy filling of powders or granules. The advantages of hard gelatin capsules include their ability to encapsulate a wide variety of substances, their ease of handling, and their suitability for various applications, including pharmaceuticals and health supplements. Additionally, hard capsules can be made in various sizes, which makes them versatile for a range of formulations. The extensive adoption of hard gelatin capsules in the pharmaceutical sector is largely driven by their cost-effectiveness and efficiency in drug formulation and delivery, making them an essential component of the market.

Soft Gelatin Capsules:

Soft gelatin capsules represent another important segment of the gelatin empty capsule market, characterized by their flexible, gelatinous structure. These capsules are primarily used to encapsulate liquid substances, oils, and suspensions, offering excellent bioavailability and absorption for the active ingredients. The unique formulation of soft gelatin capsules allows for the inclusion of sensitive compounds that may degrade in solid forms, making them particularly advantageous for pharmaceuticals and nutraceuticals that require precise delivery and enhanced efficacy. The demand for soft capsules is notably increasing due to the growing trend of using oil-based supplements, including omega-3 fatty acids and other essential nutrients, which are typically offered in soft gel form. This segment is gaining traction due to its consumer-friendly attributes and effective delivery mechanisms.

By Application

Pharmaceuticals:

The pharmaceutical application segment holds the largest market share of the gelatin empty capsule market, driven primarily by the growing demand for various medications in capsule form. Gelatin capsules are favored for encapsulating a wide range of pharmaceutical formulations, including powders, liquids, and granules, owing to their ability to protect sensitive active ingredients from degradation and enhance bioavailability. With the increased prevalence of chronic diseases and an aging population requiring chronic medication, the pharmaceutical sector's reliance on gelatin capsules has surged. Additionally, regulatory approvals and advancements in drug formulation techniques are facilitating the growth of this segment, as pharmaceutical companies seek efficient and compliant methods of delivering their products.

Health Supplements:

The health supplements application segment is also rapidly growing, reflecting the increasing consumer focus on health and wellness. With more individuals adopting preventive health measures and seeking supplemental nutrition, the demand for encapsulated vitamins, minerals, and herbal products is escalating. Gelatin capsules are preferred in this sector due to their ability to mask unpleasant tastes or odors associated with certain supplements, enhancing consumer acceptance. Furthermore, the trend towards personalized nutrition has led to an uptick in the development of customized supplements, often delivered in gelatin capsule form, which caters to specific health and dietary needs. As awareness around health and wellness continues to expand, this application segment is expected to create significant opportunities for manufacturers in the coming years.

Others:

The 'Others' segment, encompassing a variety of applications outside the primary pharmaceutical and health supplement categories, is gradually gaining traction within the gelatin empty capsule market. This segment includes applications in food, cosmetics, and animal health, where gelatin capsules are utilized for encapsulating flavors, fragrances, and nutritional supplements specifically designed for pets. The versatility of gelatin capsules allows them to cater to various industries effectively, driven by a consistent demand for innovative encapsulation solutions. As industries continue to explore novel applications for gelatin capsules, this segment is predicted to witness substantial growth, contributing further to the overall expansion of the gelatin empty capsule market.

By End User

Pharmaceutical Companies:

Pharmaceutical companies are a dominant end-user segment within the gelatin empty capsule market, as they significantly drive the demand for both hard and soft gelatin capsules. These companies utilize capsules for various formulations, including solid and liquid medications, given their efficacy in delivering active ingredients while ensuring patient compliance. The growth of this segment is closely tied to the increasing prevalence of chronic diseases, which necessitates long-term medication regimens requiring reliable and effective drug delivery mechanisms. Pharmaceutical companies are also investing in R&D to innovate new drug formulations, further enhancing the demand for gelatin capsules in their various applications.

Contract Research Organizations (CROs):

Contract Research Organizations (CROs) represent a unique end user segment in the gelatin empty capsule market, providing specialized services to pharmaceutical companies, especially in the realms of drug development and clinical trials. CROs often rely on gelatin capsules for their client services due to their versatility in formulations and ease of testing. The growth of this segment is propelled by the increasing outsourcing trends within the pharmaceutical industry, as companies seek to minimize costs and expedite their drug development processes. The demand for gelatin capsules in CROs is expected to rise in conjunction with the expanding pharmaceutical pipeline and the necessity for efficient clinical trial methodologies.

Nutraceutical Companies:

Nutraceutical companies play a vital role in the gelatin empty capsule market, leveraging the health and wellness trend among consumers. These companies produce dietary supplements that are increasingly delivered in gelatin capsule form due to their efficacy in providing targeted nutrition. As consumers become more health-conscious and seek out convenient means to incorporate dietary supplements into their routines, nutraceutical companies are focusing on innovative formulations that often utilize gelatin capsules. This end-user segment is projected to grow significantly, driven by the increasing demand for personalized nutrition and the expanding market for plant-based and vegetarian alternatives to traditional gelatin capsules.

Others:

The 'Others' end-user segment encompasses a diverse range of industries that utilize gelatin capsules for various applications, including cosmetics and food products. In the cosmetics sector, gelatin capsules are employed for encapsulating active ingredients in skincare and beauty formulations, allowing for effective delivery and enhanced stability. Similarly, in the food industry, gelatin capsules are utilized for flavor encapsulation and nutritional supplementation. The versatility of gelatin capsules in catering to the needs of diverse industries is expected to drive growth in this segment, as companies continue to explore innovative applications and formulations.

By Size

Size 000:

Size 000 capsules are the largest available gelatin capsules, designed to accommodate high-volume formulations. They are often used for products requiring a substantial dosage of active ingredients, such as bulk vitamins or herbal supplements. The preference for size 000 capsules is primarily seen in the nutraceutical and pharmaceutical sectors, where higher dosage volumes are necessary. The demand for size 000 capsules is anticipated to increase, particularly as health supplements trend toward higher dosages to meet consumer needs for effective and potent formulations. Consequently, size 000 capsules are expected to remain a significant component of the gelatin capsule market.

Size 00:

Size 00 capsules are among the most popular choices in the gelatin empty capsule market, offering a balanced capacity suitable for a wide range of applications. These capsules are commonly used in the pharmaceutical industry for various tablets and powder formulations, as they provide an optimal dosage range for many active ingredients. The versatility of size 00 capsules, coupled with their ability to mask unpleasant tastes, makes them a favored choice for both manufacturers and consumers. As the demand for diverse capsule formulations grows, size 00 capsules are expected to hold a significant position in the market.

Size 0:

Size 0 capsules are frequently utilized in pharmaceutical and health supplement formulations, providing a moderate capacity that is well-suited for a variety of applications. These capsules are often preferred by companies aiming to deliver precise dosages of active ingredients while maintaining ease of ingestion for consumers. The demand for size 0 capsules is being driven by a rise in consumer awareness regarding health and nutrition, leading to an increased need for tailored supplement solutions. As such, size 0 capsules are anticipated to contribute significantly to the gelatin capsule market’s growth.

Size 1:

Size 1 capsules are commonly used in dietary supplements and various pharmaceutical formulations, offering a smaller capacity that is ideal for many applications. Their size makes them favorable for consumers who may have difficulty swallowing larger capsules, thus enhancing patient compliance. The increasing consumer focus on health and wellness is driving a surge in demand for size 1 capsules, particularly in the nutraceutical sector, where convenience and ease of use are crucial. As manufacturers continue to innovate in capsule formulations, size 1 capsules are expected to maintain a strong presence in the market.

Size 2:

Size 2 capsules are widely utilized for dietary supplements, vitamins, and pharmaceuticals that require moderate dosages. They are popular due to their manageable size, making them suitable for various demographic groups, including children and the elderly. The rising trend of self-medication and the growing awareness of nutritional supplementation are driving demand for size 2 capsules. As the market for health supplements continues to expand, size 2 capsules are likely to play a significant role in meeting consumer preferences for effective and easy-to-swallow formulations.

Size 3:

Size 3 capsules are smaller in diameter, making them an attractive option for consumers seeking easy-to-handle supplements. These capsules are often utilized for formulations requiring lower dosages, particularly in the health supplement sector, where convenience is a priority. The growing interest in personalized nutrition and dietary management is expected to drive demand for size 3 capsules as consumers increasingly opt for tailored supplement solutions that are both effective and easy to consume. Size 3 capsules are thus anticipated to maintain a crucial position in the overall gelatin capsule market.

Size 4:

Size 4 capsules, being one of the smallest options available, cater to a specific segment of consumers who may find larger capsules difficult to ingest. These capsules are often used for vitamins, minerals, and herbal supplements that require lower dosages. As consumer preferences continue to shift towards smaller, easy-to-swallow supplements, size 4 capsules are poised for growth within the market. The increasing emphasis on health and wellness, coupled with the demand for more digestible forms of nutrients, is likely to enhance the growth prospects for size 4 capsules moving forward.

By Region

The regional analysis of the gelatin empty capsule market highlights significant growth opportunities across various geographical areas, with North America and Europe being the leading markets. North America is projected to hold the largest market share, driven by the extensive pharmaceutical and nutraceutical industries. The increasing prevalence of chronic diseases and the growing focus on health and wellness among consumers are expected to bolster demand for gelatin capsules in this region. Meanwhile, Europe is anticipated to experience steady growth, driven by regulatory support for the pharmaceutical sector and a substantial demand for health supplements. The CAGR of the gelatin empty capsule market in Europe is expected to remain robust, reflecting the region's focus on innovative drug delivery systems and personalized medications.

Asia Pacific is poised to witness the highest growth rate during the forecast period, fueled by the rising investments in the pharmaceutical sector and increasing health awareness among consumers. The growing population, along with a rising middle class in countries like India and China, is leading to heightened demand for health supplements and pharmaceuticals, thereby enhancing the market for gelatin capsules. Additionally, Latin America and the Middle East & Africa are also expected to contribute to market growth, owing to a growing emphasis on healthcare improvements and the expansion of the nutraceutical industry. Overall, the regional dynamics of the gelatin empty capsule market reflect a diverse landscape of opportunities for manufacturers and stakeholders.

Opportunities

The gelatin empty capsule market is poised to benefit significantly from the increasing trend toward personalized nutrition and customized health products. As consumers become more health-conscious, there is a growing demand for tailored supplements that can cater to individual dietary needs and preferences. This trend presents a unique opportunity for manufacturers to innovate and develop specialized gelatin capsules that can encapsulate unique formulations, whether for vitamins, minerals, or herbal supplements. By leveraging their expertise in capsule technology, companies can create products that not only meet consumer demands but also enhance their market positioning and brand loyalty. Furthermore, the rise of e-commerce and online pharmacies is making it easier for consumers to access a wide variety of capsule products, thereby expanding market reach and driving sales.

Another crucial opportunity lies in the increasing research and development efforts aimed at creating vegetarian and vegan alternatives to traditional gelatin capsules. With rising awareness regarding dietary restrictions and preferences, particularly among health-conscious consumers and those adhering to plant-based diets, the demand for alternative capsules is expected to grow. Manufacturers who invest in developing plant-based capsule options can capitalize on this emerging trend and cater to an expanding consumer base. Additionally, there is potential for growth in emerging markets, where the increasing availability of healthcare services and the expanding pharmaceutical industry can drive the demand for effective drug delivery systems, including gelatin capsules. As these markets continue to develop, they present a fertile ground for expansion and innovation in the gelatin empty capsule sector.

Threats

Despite the promising growth trajectory of the gelatin empty capsule market, several threats exist that could impede its expansion. One significant threat is the rise of stringent regulatory frameworks governing the pharmaceutical and nutraceutical industries. As governments increasingly prioritize consumer safety and product efficacy, compliance with these regulations can pose challenges for manufacturers. For instance, the need for rigorous testing and certification of gelatin capsules can lead to increased operational costs and extended time-to-market for new products. Additionally, regulatory changes can impact the availability of raw materials used in capsule production, which could further strain the supply chain and affect production schedules. The requirement for transparency in ingredient sourcing and manufacturing processes could also necessitate additional investments in quality control and assurance, creating a potential burden on manufacturers.

Another pressing threat to the gelatin empty capsule market is the growing competition from alternative drug delivery systems, including tablets and liquid formulations. As consumers seek out diverse options for medication and supplements, the market faces the challenge of differentiating gelatin capsules from other delivery forms. The emergence of advanced technologies, such as nanotechnology and sustained-release formulations, has led to the development of innovative alternatives that may outperform traditional gelatin capsules in terms of bioavailability and efficacy. Consequently, companies must continuously innovate and adapt their product offerings to remain competitive in a landscape that is rapidly evolving. The increasing consumer demand for natural and organic products may also challenge gelatin capsules, especially if consumers express concerns regarding the sourcing of animal-derived ingredients.

Competitor Outlook

• Capsule Corporation
• Qualicaps
• Lonza Group AG
• ACG Worldwide
• Faspack
• Suheung Co., Ltd.
• Zhejiang Jianfeng Capsule Co., Ltd.
• Roquette Frères
• Sedana Medical AB
• Capsugel (now part of Lonza)
• Gelita AG
• Roxlor
• Shandong Qilu Pharmaceutical Co., Ltd.
• Hunan Er-Kang Pharmaceutical Co., Ltd.
• Eligo Bioscience

The competitive landscape of the gelatin empty capsule market is characterized by a diverse range of players, ranging from established multinational corporations to niche manufacturers specializing in specific capsule types. Leading companies such as Lonza, Qualicaps, and ACG Worldwide dominate the market with their extensive product portfolios and global reach. These key players leverage their advanced technologies and strong distribution networks to provide a comprehensive range of gelatin capsules tailored to meet the needs of various applications. Additionally, many of these companies invest heavily in research and development to continuously innovate their product offerings, thereby maintaining a competitive edge in the fast-evolving market.

Moreover, the market is witnessing an increase in collaborations, mergers, and acquisitions among competitors seeking to enhance their market share and expand their capabilities. For instance, Lonza's acquisition of Capsugel has allowed the company to broaden its portfolio and cater to the growing demand for innovative drug delivery systems. This consolidation trend not only strengthens the competitive position of established players but also enables them to better meet the diverse needs of pharmaceutical and nutraceutical companies. Furthermore, the entry of regional players into the market is intensifying competition, as these companies aim to capture local market shares by offering cost-effective solutions that resonate with consumer preferences.

Overall, the gelatin empty capsule market remains dynamic and competitive, with numerous companies actively pursuing growth strategies to capitalize on emerging opportunities. Companies such as Gelita AG and Roxlor are focusing on sustainability and developing vegetarian and vegan alternatives to traditional gelatin capsules, catering to the growing demand for plant-based products. These strategic initiatives, coupled with ongoing technological advancements in capsule formulation and production, are expected to shape the future of the market. As competition continues to intensify, industry participants must remain vigilant and responsive to changing market dynamics to ensure sustained growth and success.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Roxlor
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Faspack
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Gelita AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Qualicaps
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 ACG Worldwide
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Lonza Group AG
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Eligo Bioscience
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Sedana Medical AB
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Suheung Co., Ltd.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Capsule Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Roquette Frères
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Capsugel (now part of Lonza)
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Zhejiang Jianfeng Capsule Co., Ltd.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Hunan Er-Kang Pharmaceutical Co., Ltd.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Shandong Qilu Pharmaceutical Co., Ltd.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Gelatin Empty Capsule Market, By Size
    • 6.1.1 Size 000
    • 6.1.2 Size 00
    • 6.1.3 Size 0
    • 6.1.4 Size 1
    • 6.1.5 Size 2
    • 6.1.6 Size 3
    • 6.1.7 Size 4
  • 6.2 Gelatin Empty Capsule Market, By End User
    • 6.2.1 Pharmaceutical Companies
    • 6.2.2 Contract Research Organizations
    • 6.2.3 Nutraceutical Companies
    • 6.2.4 Others
  • 6.3 Gelatin Empty Capsule Market, By Application
    • 6.3.1 Pharmaceuticals
    • 6.3.2 Health Supplements
    • 6.3.3 Others
  • 6.4 Gelatin Empty Capsule Market, By Product Type
    • 6.4.1 Hard Gelatin Capsules
    • 6.4.2 Soft Gelatin Capsules

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Gelatin Empty Capsule Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Gelatin Empty Capsule market is categorized based on

By Product Type

• Hard Gelatin Capsules
• Soft Gelatin Capsules

By Application

• Pharmaceuticals
• Health Supplements
• Others

By End User

• Pharmaceutical Companies
• Contract Research Organizations
• Nutraceutical Companies
• Others

By Size

• Size 000
• Size 00
• Size 0
• Size 1
• Size 2
• Size 3
• Size 4

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Capsule Corporation
• Qualicaps
• Lonza Group AG
• ACG Worldwide
• Faspack
• Suheung Co., Ltd.
• Zhejiang Jianfeng Capsule Co., Ltd.
• Roquette Frères
• Sedana Medical AB
• Capsugel (now part of Lonza)
• Gelita AG
• Roxlor
• Shandong Qilu Pharmaceutical Co., Ltd.
• Hunan Er-Kang Pharmaceutical Co., Ltd.
• Eligo Bioscience